Details of the Drug Reposition

General Information of This Drug (ID: DM6A0X7)

• Drug Name: Pravastatin (DM6A0X7)
• Synonyms: Eptastatin; Oliprevin; Pravastatina; Pravastatine; Pravastatinum; Pravator; Vasten; Pravastatin Sodium Salt; Pravastatina [Spanish]; Pravastatine [French]; Pravastatinum [Latin]; KS-5015; Pravachol (TN); Pravastatin (INN); Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravator (TN); RMS-431; Selektine (TN); SQ-31,000; (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid
• Therapeutic Class: Anticholesteremic Agents
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

4 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Hyperlipidemia, familial combined, LPL related	DISL1CE3	N.A.	Approved	[1]
Adult acute monocytic leukemia	DISG6BLX	N.A.	Approved	[1]
Hypertriglyceridemia	DIS7SN6U	5C80.1	Approved	[1]
Arteriosclerosis	DISK5QGC	BD40	Approved	[1]

1 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Stroke	DISX6UHX	8B20	Investigative	[1]

References

• [1] Pravastatin FDA Label